Sources | Names Used |
---|---|
GDSC1000 | QL-VIII-58 |
PharmacoGx | QL-VIII-58 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLD1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | CYP4F3 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | GSN | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | PYGL | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | ZNF541 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | SARM1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
mRNA | PIEZO1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | TAF13 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | ARHGEF10 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | HMGB1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |